2024 Update on the GLP-1 Inhibitor Landscape: Evolution of Metabolic Medicine
In this 2026 retrospective, we analyze the 2024 landscape of GLP-1 receptor agonists, a year that redefined these drugs from simple weight-loss aids t...
Lifestyle & Learning
